Hongrui Meng | RNA biology | Best Researcher Award

Published on by Cell Biologist

Dr. Hongrui Meng | RNA biology | Best Researcher Award

Dr. Hongrui Meng, Institute of Neuroscience, Soochow University, China

Dr. Hongrui Meng is a distinguished neuroscientist specializing in the molecular mechanisms underlying neurodegenerative diseases. With a Ph.D. in Behavioral Neuroscience from Hamamatsu University School of Medicine, Japan, Dr. Meng furthered his expertise through postdoctoral training at Juntendo University, Tokyo. He served as an assistant professor before establishing the Laboratory of Molecular Neurology at the Institute of Neuroscience, Soochow University, where he became a full professor in 2020. His pioneering work has made notable advances in understanding Parkinson’s disease, ALS, and mitochondrial dysfunction. Dr. Meng’s research integrates cellular, genetic, and biochemical tools using models ranging from Drosophila to mice. He has authored over a dozen peer-reviewed publications and holds international patents for novel molecular diagnostic techniques. Additionally, he collaborates with pharmaceutical companies to develop plant-based neuroprotective agents. As a committed mentor and leader, he contributes to scientific societies and editorial boards and is known for his translational approach in bridging basic science and therapeutic innovation.

Publication Profile: 

Scopus

Orcid

✅ Strengths for the Award:

  1. Pioneering Research in Neurodegeneration:
    Dr. Meng has significantly contributed to understanding the molecular and cellular mechanisms of neurodegenerative diseases, especially Parkinson’s disease and ALS, with a focus on mitochondrial dysfunction, protein aggregation, and innate immunity.

  2. International Academic Background and Collaborations:
    Educated and trained in Japan with active collaborations in both academic and industry sectors (e.g., Longma Pharmaceutical Co., Ltd.), Dr. Meng bridges global perspectives and translational goals effectively.

  3. Strong Publication and Patent Record:
    He has published over a dozen high-impact, peer-reviewed articles (SCI, Scopus indexed) and holds international patents in diagnostic methodology. His research output demonstrates consistency, innovation, and real-world applicability.

  4. Leadership in Research and Lab Management:
    As a full professor and founder of the Laboratory of Molecular Neurology at Soochow University, Dr. Meng leads a dynamic team with successful research grants, including from JSPS, NSFC, and Takeda Foundation.

  5. Interdisciplinary Focus:
    His work integrates behavioral neuroscience, molecular biology, genetics, and technology (e.g., wearable devices), illustrating a forward-looking and solution-oriented approach.

🛠️ Areas for Improvement:

  • Citation Impact (h-index):
    While his Scopus h-index (7) reflects a solid foundation, increased international visibility and broader citation engagement can elevate his standing among global peers.

  • Expanded Global Outreach:
    More international speaking engagements, global consortia leadership, and multi-center trials could further boost Dr. Meng’s influence and accelerate translation of his work.

🎓 Education:

Dr. Hongrui Meng earned his Ph.D. in Behavioral Neuroscience from Hamamatsu University School of Medicine, Japan. His doctoral research focused on neurobiological pathways implicated in behavioral disorders and neurodegenerative processes. Following this, he underwent rigorous postdoctoral training at Juntendo University in Tokyo, where he specialized in molecular neurobiology and human genetics. His interdisciplinary education and training provided him with a strong foundation in genetic, molecular, and cellular neuroscience, particularly as they relate to Parkinson’s disease and ALS. His academic journey was shaped by prestigious institutions known for cutting-edge neuroscience research and helped develop his expertise in mitochondrial dysfunction and protein aggregation mechanisms. Dr. Meng has continued to expand his knowledge through professional development and active engagement with academic societies in both China and Japan. His educational background has prepared him well to lead impactful, translational research in neurodegenerative disease therapy and drug discovery.

🧪 Experience:

Dr. Meng began his academic career in Japan, first as a doctoral researcher and later as a postdoctoral fellow focusing on molecular neurobiology and neurogenetics. He was appointed assistant professor in the Department of Research for Neurodegenerative Diseases and Dementia at Juntendo University. In 2020, he joined the Institute of Neuroscience at Soochow University as a full professor, where he established and currently leads the Laboratory of Molecular Neurology. Over his career, Dr. Meng has managed multiple international and national research projects supported by agencies such as the Japan Society for the Promotion of Science and the Natural Science Foundation of China. His projects span from fundamental mitochondrial research to applied wearable technologies for Parkinson’s monitoring. With over 12 years of research and academic leadership, he also provides consultancy to pharmaceutical companies and reviews for educational institutions. His international experience has made him a key contributor to the neurodegeneration research field.

🔬 Research Focus:

Dr. Meng’s research focuses on uncovering the cellular and molecular mechanisms of neurodegenerative diseases, particularly Parkinson’s disease and ALS. His lab investigates how mitochondrial dysfunction contributes to protein aggregation and neuronal death, with an emphasis on α-synuclein and CHCHD2-related pathways. Using transgenic Drosophila and rodent models, Dr. Meng’s work has identified key genetic mutations and stress response pathways, such as the mitochondrial unfolded protein response (mtUPR), that drive disease progression. His research also extends to glial cell biology, neuroinflammation, and the neuroimmune system’s role in maintaining neuronal integrity. Moreover, he is pioneering in drug discovery, developing plant-derived compounds and wearable technology for disease monitoring. His lab is currently involved in translational research, bridging basic molecular findings with therapeutic applications. Dr. Meng’s studies are multidisciplinary, combining genetics, molecular biology, imaging, and behavioral neuroscience, aiming to transform discoveries into real-world interventions for neurodegenerative conditions.

📚 Publications Top Notes:

  1. 🧬 Dicer Is Involved in Cytotoxicity and Motor Impairment Induced by TBPH Deficiency – Current Issues in Molecular Biology, 2025

  2. 🧠 Alpha-Synucleinopathy Disrupts Microglial Homeostasis in Parkinson’s Disease – Cell Communication and Signaling, 2024

  3. 🧪 Transcriptomic Analysis of Lipid Metabolism Genes in Alzheimer’s Disease – Journal of Molecular Neuroscience, 2024

  4. 🔬 CHCHD2 Mutation Alters Ca2+ Homeostasis in ALS – PNAS Nexus, 2024

  5. 🧫 A Simple Technique to Assay Locomotor Activity in Drosophila – Journal of Visualized Experiments, 2023

  6. 🧍‍♂️ MHCI Deficiency Induces ADHD-like Symptoms – Brain Behavior and Immunity, 2021

  7. 🧠 Twin CHCH Proteins in Parkinson’s and ALS – International Journal of Molecular Sciences, 2019

  8. 🧪 CHCHD2 Mutations Cause Alpha-Synuclein Aggregation – Human Molecular Genetics, 2019

  9. 🧬 Monitoring Mitochondrial Changes via Pink1-Parkin Signaling in Drosophila – Methods in Molecular Biology, 2018

  10. 🧪 Loss of CHCHD2 Affects Mitochondrial Cristae and Cytochrome C – Nature Communications, 20

🧾 Conclusion:

Dr. Hongrui Meng exemplifies the qualities of a top-tier neuroscientist: innovation, academic rigor, leadership, and translational vision. His multidisciplinary work contributes directly to unmet clinical needs in Parkinson’s and ALS, backed by strong research funding, publications, and patent activities.

Wahiduzzaman Emon | RNA Biology Function | Best Researcher Award

Published on by Cell Biologist

Mr. Wahiduzzaman Emon | RNA Biology Function | Best Researcher Award

Mr. Wahiduzzaman Emon , Aix Marseille University , France

Wahiduzzaman Emon is a promising researcher in the field of optics, photonics, and biosensing. Currently pursuing a Joint M.Sc in Optics & Photonics through the Erasmus Mundus Europhotonics program, he is studying at Aix Marseille University, France, and Tampere University, Finland. Emon has a strong academic background with a B.Sc. in Electrical and Electronic Engineering from Ahsanullah University of Science & Technology, Bangladesh. With numerous awards, including an Erasmus Mundus scholarship and the Dean’s List Award, he has demonstrated exceptional skills in research. Emon’s work is primarily focused on developing advanced biosensors using surface plasmon resonance (SPR), plasmonic materials, and 2D materials for applications in cancer detection and environmental monitoring. His research contributions are well-recognized through multiple publications in prestigious journals and conferences.

Publication Profile:

Google Scholar

Strengths for the Award:

Wahiduzzaman Emon is a highly accomplished researcher with exceptional academic performance and technical expertise in optics, photonics, and biosensors. His work on advanced plasmonic biosensors, particularly using photonic crystal fibers (PCFs) for cancer detection and bacterial diagnostics, demonstrates innovative thinking and a strong capacity for impactful research. He has published multiple papers in respected journals and conferences, and his contributions to designing novel biosensors for healthcare applications show great promise in both academic and practical contexts. His research is not only technically rigorous but also socially relevant, aiming to improve diagnostics in cancer and infectious diseases.

Areas for Improvement:

While Emon’s research is impressive, expanding his network and increasing international collaborations can further enhance his visibility and the impact of his work. Additionally, diversifying his research into more interdisciplinary fields could offer broader insights into emerging technologies. Working on scaling his designs from theoretical models to prototype stages could also enhance the real-world applicability of his innovations.

Education:

Wahiduzzaman Emon is currently enrolled in a Joint M.Sc in Optics & Photonics under the prestigious Erasmus Mundus Europhotonics program. He is studying at Aix Marseille University in France and Tampere University in Finland from September 2024 to 2026. Before this, he completed his B.Sc. in Electrical and Electronic Engineering at Ahsanullah University of Science & Technology in Dhaka, Bangladesh, where he achieved a CGPA of 3.848/4.00, ranking in the top 5% of his class. His undergraduate thesis focused on a highly sensitive ZnO/Ag/BaTiO3/MoS2 hybrid structure-based surface plasmon biosensor for detecting Mycobacterium tuberculosis. This solid educational foundation has laid the groundwork for his deep interest and excellence in the fields of optics, photonics, and biosensing technologies, paving the way for his future success in cutting-edge research.

Experience:

Wahiduzzaman Emon has gained valuable research experience through multiple projects and collaborations. As a Research Assistant in the Department of Electrical and Electronic Engineering at Ahsanullah University of Science & Technology, Bangladesh, from May to August 2024, he contributed significantly to researching surface plasmon resonance (SPR)-based sensors for cancer and chemical detection. He co-supervised undergraduate theses on sensor development and conducted extensive simulations. His research experience also includes designing advanced photonic crystal fibers (PCF) for communication and sensing applications, including significant work on CT-PCF design for enhanced birefringence and nonlinearity, published in several conferences. In addition, Emon worked on the development of SPR biosensors for detecting cancerous cells in collaboration with Taif University, Saudi Arabia. His extensive use of COMSOL Multiphysics, MATLAB, and OriginPro for modeling and simulations has enhanced his expertise in biosensors and photonic devices.

Awards and Honors:

Wahiduzzaman Emon’s academic journey has been marked by several prestigious awards and honors. He was awarded the Erasmus Mundus Scholarship for his Joint M.Sc in Optics & Photonics from September 2024 to 2026, a highly competitive award that recognizes exceptional international talent. In his undergraduate studies, Emon was consistently recognized for his academic excellence, earning the Dean’s List Award for outstanding performance at Ahsanullah University of Science & Technology, Dhaka, Bangladesh, from 2020 to 2024. He was also named the Champion of the Final Year Thesis Project competition in May 2024, where his thesis on plasmonic biosensors outperformed other projects in the Electronics department. These accolades underscore Emon’s academic abilities and his potential for contributing significantly to the fields of photonics, biosensing, and optical sciences.

Research Focus:

Wahiduzzaman Emon’s research primarily focuses on the development of advanced biosensors, with particular interest in surface plasmon resonance (SPR), plasmonic materials, and 2D materials. His work aims to enhance the sensitivity and specificity of biosensors for applications in cancer detection, tuberculosis diagnosis, and environmental monitoring. Emon’s research in photonic crystal fibers (PCF) explores their use in improving optical communication systems and developing plasmonic biosensors. He has designed multi-layered SPR sensors for cancer cell detection and explored novel materials such as ZnO/Ag/BaTiO3/MoS2 hybrid structures to improve biosensor performance. By combining computational tools like COMSOL Multiphysics and MATLAB, Emon is working on creating innovative solutions to increase the efficiency and reliability of biosensing devices. His contributions to photonics, biosensors, and plasmonics have the potential to make significant impacts on healthcare and environmental monitoring.

Publications Top Notes:

  • W. Emon, M. F. Nayan, S. Salehin, A. Chaki, S. Tuba, K. M. Ishtiak, “Highly sensitive ZnO/Ag/BaTiO3/MoS2 hybrid structure-based surface plasmon biosensor for the detection of mycobacterium tuberculosis bacteria,” Optics Continuum, vol. 3, no. 3, pp. 495-512, 2024. 🌟
  • W. Emon, A. Chaki, T. P. Mondal, M. D. F. Nayan, R. R. Mahmud, “Photonic crystal fiber-based SPR biosensor coated with Ag-TiO2 and Au-TiO2 for the detection of skin cancer: a comparison,” Optical and Quantum Electronics, vol. 56, no. 8, article 1322, 2024. 🧬
  • W. Emon, A. Chaki, F. K. Nahian, M. D. F. Nayan, R. R. Mahmud, “Performance Analysis of Ag-TiO2-Coated Hexagonal-Shaped Photonic Crystal Fiber Plasmonic Sensor and Ethanol’s Low Water Content Detection,” Plasmonics, pp. 1-13, 2024. 🔬
  • S. A. Rafi, W. Emon, A. A. Rafsan, R. R. Mahmud, M. F. Nayan, M. M. A. Eid, “Optical Based Surface Plasmon Resonance Sensor for the Detection of the Various Kind of Cancerous Cell,” Cell Biochemistry and Biophysics, pp. 1-27, 2024. 🧪
  • A. Halder, W. Emon, M. S. Anower, M. R. Tanshen, M. Forkan, M. S. U. Shajib, “Design and numerical analysis of ultra-high negative dispersion, highly birefringent nonlinear single mode core-tune photonic crystal fiber (CT-PCF) over communication bands,” Optics and Photonics Journal, vol. 13, no. 10, pp. 227-242, 2023. 🌐

Conclusion:

Given his academic achievements, research excellence, and dedication to advancing photonic technologies, Wahiduzzaman Emon is a highly deserving candidate for the Best Researcher Award. His innovative contributions, especially in the design of biosensors, make him an excellent representative of cutting-edge research in optics and photonics.